240 related articles for article (PubMed ID: 21811615)
1. Arginase 2 deletion reduces neuro-glial injury and improves retinal function in a model of retinopathy of prematurity.
Narayanan SP; Suwanpradid J; Saul A; Xu Z; Still A; Caldwell RW; Caldwell RB
PLoS One; 2011; 6(7):e22460. PubMed ID: 21811615
[TBL] [Abstract][Full Text] [Related]
2. Arginase 2 deficiency reduces hyperoxia-mediated retinal neurodegeneration through the regulation of polyamine metabolism.
Narayanan SP; Xu Z; Putluri N; Sreekumar A; Lemtalsi T; Caldwell RW; Caldwell RB
Cell Death Dis; 2014 Feb; 5(2):e1075. PubMed ID: 24556690
[TBL] [Abstract][Full Text] [Related]
3. Deletion of Arginase 2 Ameliorates Retinal Neurodegeneration in a Mouse Model of Multiple Sclerosis.
Palani CD; Fouda AY; Liu F; Xu Z; Mohamed E; Giri S; Smith SB; Caldwell RB; Narayanan SP
Mol Neurobiol; 2019 Dec; 56(12):8589-8602. PubMed ID: 31280447
[TBL] [Abstract][Full Text] [Related]
4. Oxygen-induced retinopathy induces short-term glial stress and long-term impairment of photoentrainment in mice.
Mehdi MK; Sage-Ciocca D; Challet E; Malan A; Hicks D
Graefes Arch Clin Exp Ophthalmol; 2014 Apr; 252(4):595-608. PubMed ID: 24509649
[TBL] [Abstract][Full Text] [Related]
5. Arginase 2 promotes neurovascular degeneration during ischemia/reperfusion injury.
Shosha E; Xu Z; Yokota H; Saul A; Rojas M; Caldwell RW; Caldwell RB; Narayanan SP
Cell Death Dis; 2016 Nov; 7(11):e2483. PubMed ID: 27882947
[TBL] [Abstract][Full Text] [Related]
6. Long-term evaluation of retinal morphology and function in a mouse model of oxygen-induced retinopathy.
Mezu-Ndubuisi OJ; Macke EL; Kalavacherla R; Nwaba AA; Suscha A; Zaitoun IS; Ikeda A; Sheibani N
Mol Vis; 2020; 26():257-276. PubMed ID: 32256029
[TBL] [Abstract][Full Text] [Related]
7. Characterization of retinal function and glial cell response in a mouse model of oxygen-induced retinopathy.
Vessey KA; Wilkinson-Berka JL; Fletcher EL
J Comp Neurol; 2011 Feb; 519(3):506-27. PubMed ID: 21192081
[TBL] [Abstract][Full Text] [Related]
8. Arginase 2 deficiency prevents oxidative stress and limits hyperoxia-induced retinal vascular degeneration.
Suwanpradid J; Rojas M; Behzadian MA; Caldwell RW; Caldwell RB
PLoS One; 2014; 9(11):e110604. PubMed ID: 25375125
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity.
Saito Y; Geisen P; Uppal A; Hartnett ME
Mol Vis; 2007 Jun; 13():840-53. PubMed ID: 17615545
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of aldose reductase attenuates inner retinal neuronal changes in a mouse model of retinopathy of prematurity.
Fu Z; Nian S; Li SY; Wong D; Chung SK; Lo AC
Graefes Arch Clin Exp Ophthalmol; 2015 Sep; 253(9):1503-13. PubMed ID: 25921391
[TBL] [Abstract][Full Text] [Related]
11. Anti-apoptotic effect of interleukin-17 in a mouse model of oxygen-induced retinopathy.
Li N; Gao S; Wang J; Zhu Y; Shen X
Exp Eye Res; 2019 Oct; 187():107743. PubMed ID: 31348907
[TBL] [Abstract][Full Text] [Related]
12. Neuronal and glial cell changes are determined by retinal vascularization in retinopathy of prematurity.
Downie LE; Pianta MJ; Vingrys AJ; Wilkinson-Berka JL; Fletcher EL
J Comp Neurol; 2007 Oct; 504(4):404-17. PubMed ID: 17663451
[TBL] [Abstract][Full Text] [Related]
13. Retinal Neuroprotection From Optic Nerve Trauma by Deletion of Arginase 2.
Xu Z; Fouda AY; Lemtalsi T; Shosha E; Rojas M; Liu F; Patel C; Caldwell RW; Narayanan SP; Caldwell RB
Front Neurosci; 2018; 12():970. PubMed ID: 30618589
[TBL] [Abstract][Full Text] [Related]
14. Effect of subretinal injection on retinal structure and function in a rat oxygen-induced retinopathy model.
Becker S; Wang H; Stoddard GJ; Hartnett ME
Mol Vis; 2017; 23():832-843. PubMed ID: 29259390
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous assessment of aberrant retinal vascularization, thickness, and function in an in vivo mouse oxygen-induced retinopathy model.
Mezu-Ndubuisi OJ; Adams T; Taylor LK; Nwaba A; Eickhoff J
Eye (Lond); 2019 Mar; 33(3):363-373. PubMed ID: 30209267
[TBL] [Abstract][Full Text] [Related]
16. Targeting proliferative retinopathy: Arginase 1 limits vitreoretinal neovascularization and promotes angiogenic repair.
Fouda AY; Xu Z; Suwanpradid J; Rojas M; Shosha E; Lemtalsi T; Patel C; Xing J; Zaidi SA; Zhi W; Stansfield BK; Cheng PN; Narayanan SP; Caldwell RW; Caldwell RB
Cell Death Dis; 2022 Aug; 13(8):745. PubMed ID: 36038541
[TBL] [Abstract][Full Text] [Related]
17. Aldose reductase deficiency reduced vascular changes in neonatal mouse retina in oxygen-induced retinopathy.
Fu ZJ; Li SY; Kociok N; Wong D; Chung SK; Lo AC
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5698-712. PubMed ID: 22836764
[TBL] [Abstract][Full Text] [Related]
18. Adenosine A1 Receptors Selectively Modulate Oxygen-Induced Retinopathy at the Hyperoxic and Hypoxic Phases by Distinct Cellular Mechanisms.
Zhang S; Li H; Li B; Zhong D; Gu X; Tang L; Wang Y; Wang C; Zhou R; Li Y; He Y; Chen M; Huo Y; Liu XL; Chen JF
Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8108-19. PubMed ID: 26720463
[TBL] [Abstract][Full Text] [Related]
19. Proteomic profiling of the retinas in a neonatal rat model of oxygen-induced retinopathy with a reproducible ion-current-based MS1 approach.
Tu C; Beharry KD; Shen X; Li J; Wang L; Aranda JV; Qu J
J Proteome Res; 2015 May; 14(5):2109-2120. PubMed ID: 25780855
[TBL] [Abstract][Full Text] [Related]
20. Endothelial arginase 2 mediates retinal ischemia/reperfusion injury by inducing mitochondrial dysfunction.
Shosha E; Fouda AY; Lemtalsi T; Haigh S; Fulton D; Ibrahim A; Al-Shabrawey M; Caldwell RW; Caldwell RB
Mol Metab; 2021 Nov; 53():101273. PubMed ID: 34139341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
